CTOs on the Move


 
  • Number of Employees:
  • Annual Revenue:

  • ,

Executives

Name Title Contact Details

Similar Companies

Safe & Green Holdings Corp.

Safe & Green Holdings Corp., a leading modular solutions company, operates under core capabilities which include the development, design, and fabrication of modular structures, meeting the demand for safe and green solutions across various industries. The firm supports third party and in-house developers, architects, builders and owners in achieving faster execution, greener construction, and buildings of higher value. SGH Corp. products have been featured in several media outlets including Fortune, NY Times, NY Post, USA Today, CNN, Washington Post and more. The company has completed projects for: US Army and Navy, US Department of Veteran Affairs, The City of Santa Monica, Port of Houston Authority, Aman Resorts, BareBurger, Equinox, HGTV, Lacoste, Marriott Hotels & Resorts, Mini Cooper, Starbucks and more.

CounselX

At CounselX, we carefully listen to your unique needs and aspirations, showing our dedication to solve your three hard problems: Facilitating Enterprise Client and Law firms: Connecting enterprise clients with specialized legal talent for efficient outsourcing of specific legal tasks. This is me: https://shorturl.at/ctELY Supporting Legal Professionals: Offering a platform for legal experts to find flexible, additional work opportunities that utilize their skills and experience. This is me: https://shorturl.at/eqsAD Empowering Startups: Providing subscription-based legal services to help startups establish strong legal foundations and focus on growth through on-going support. This is me: https://shorturl.at/asKOT

Ninety Nine Restaurant & Pub

The Ninety Nine Restaurant & Pub is headquartered in Woburn, Massachusetts, and has earned a strong reputation as a friendly, comfortable place to gather and enjoy great food and great drink at a terrific price. With the establishment of the Ninety Nine Restaurant & Pub in 1952, founder Charlie Doe created an entirely new niche in the New England hospitality industry – the casual restaurant – long before the appearance of others. The Ninety Nine Restaurant & Pub continues to prosper and grow. The Ninety Nine updates and refines its menu on an ongoing basis to provide guests with fresh new options, yet continues to offer great food and great drink at a terrific price. This philosophy began when the company was founded, and is still maintained today. The culture at the Ninety Nine Restaurant & Pub was instilled by Charlie Doe long before a mission statement was ever written down on paper. But the proclamation means that guests, team members, community and stakeholders are treated with respect. For guests, it means they have a friendly, comfortable place to gather and enjoy great food and great drink at a terrific price. The Ninety Nine is proud to serve more than 20 million customers a year in over 105 restaurants throughout the Northeast. For team members it translates into accommodating work schedules, generous benefits, including 401(k) plans and health, life and dental insurance (for hourly and part-time team members as well); and plentiful rewards for top performers.

Leadership Pipeline Institute

With Stephen Drotter, author of The Leadership Pipeline and The Performance Pipeline, as Chairman, Leadership Pipeline Institute is the official research institute and leading global provider of solutions based on the two pipeline books, which have sold more than 300,000 copies around the world. The Leadership Pipeline institute is: • The leading global provider of Leadership Pipeline and Specialist Pipeline solutions to private and public organizations • The leading organization for research within the Leadership Pipeline and Specialist Pipeline arena • The global "magnet"​ for everyone with an interest in the Leadership Pipeline and Specialist concept and how it is applied Today, the Leadership Pipeline is perceived as one of the most influential leadership models through the last two decades. A significant number of the FORTUNE 500 companies have successfully implemented the Leadership Pipeline as their main leadership infrastructure for selecting and growing leaders at all levels and it has seamlessly been applied to corporate, non-profit and public organizations around the world. Leadership Pipeline Institute is specialized in supporting organizations building an internal pipeline of qualified leaders and specialists and in creating empowered, performance- and execution-focused organizations. Working with Leadership Pipeline Institute, you will receive acknowledged hands-on solutions that can be easily customized to your organization and are based on the latest applied global research and experience from some of the worlds most successful companies.

IMUNON

IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.